Release date: 2010-06-23
 

Imec Reports Asymetric Nanostructures for Early and More Accurate Prediction of Cancer
 

(Newswire Today) —  Anaheim, CA, United States, 2010-06-23 - Researchers at the nanotechnology research centre imec (Leuven, Belgium) have demonstrated biosensors based on novel nanostructure geometries.

   
 

Researchers at the nanotechnology research centre imec have demonstrated biosensors based on novel nanostructure geometries that increase the sensitivity and allow to detect extremely low concentrations of specific disease markers. This paves the way to early diagnostics of for example cancer by detecting low densities of cancer markers in human blood samples.

Functionalized nanoparticles can identify and measure extremely low concentrations of specific molecules. They enable the realization of diagnostic systems with increased sensitivity, specificity and reliability resulting in a better and more cost-efficient healthcare. And, going one step further, functionalized nanoparticles can help treat diseases, by destroying the diseased cells that the nanoparticles bind to.

Imec aims at developing biosensor systems exploiting a phenomenon known as localized surface plasmon resonance in noble metal (e.g. gold and silver) nanostructures. The biosensors are based on optical detection of a change in spectral response of the nanostructures upon binding a disease marker. The detection sensitivity can be increased by changing the morphology and size of the noble metal nanostructures. The biosensor system is cheap and easily extendable to multiparameter biosensing. Imec today presents broken symmetry gold nanostructures that combine nanorings with nanodiscs. Combining different nanostructures in close proximity allows detailed engineering of the plasmon resonance of the nanostructures. More specifically, imec targeted an optimization of both the width of the resonance peak and the resonance shift upon binding of the disease marker. With respect to these parameters, the new geometries clearly outperform the traditional nanospheres. Therefore, they are better suited for practical use in sensitive biosensor systems.

“With our bio-nano research, we aim at playing an important role in developing powerful healthcare diagnostics and therapy. We work on innovative instruments to support the research into diseases and we look into portable technologies that can diagnose diseases at an early stage. We want to help the pharmaceutical and diagnostic industry with instruments to develop diagnostic tests and therapies more efficiently;” said Prof. Liesbet Lagae, program manager HUMAN++ on biomolecular interfacing technology.

Some of these results were achieved in collaboration with the Catholic University of Leuven (Leuven, Belgium), Imperial College (London, UK) and Rice University (Houston, Texas).

About imec
Imec (imec.be) performs world-leading research in nano-electronics. Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. Imec delivers industry-relevant technology solutions. In a unique high-tech environment, its international top talent is committed to providing the building blocks for a better life in a sustainable society.

Imec is headquartered in Leuven, Belgium, and has offices in Belgium, the Netherlands, Taiwan, US, China and Japan. Its staff of more than 1,750 people includes over 550 industrial residents and guest researchers. In 2009, imec's revenue (P&L) was 275 million euro.

Imec is a registered trademark for the activities of IMEC International (a legal entity set up under Belgian law as a "stichting van openbaar nut”), imec Belgium (imec vzw supported by the Flemish Government), imec the Netherlands (Stichting imec Nederland, part of Holst Centre which is supported by the Dutch Government) and imec Taiwan (imec Taiwan Co.).

   
 

Agency / Source:

 
 
# # #
 
  Related Link: http://www2.imec.be/be_en/press/imec-news.html
 Contact name: Katrien Marent - imec.be
  Related Link:
 +32 16 28 18 80 / katrien.marent[.]imec.be
PRZOOM disclaims any content contained in these release. Our complete disclaimer appears on our disclaimer page. Issuers of releases are solely responsible for the accuracy of their content. All trademarks are the property of their respective owners.
© PRZOOM.com - NewswireToday.com - Press Release & Newswire Distribution Network.


Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)